ONYX PHARMACEUTICALS - 683399109
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2013
· Q2 2013
Value (USD)
Total reported value ($000)
$4.95M
QoQ value delta ($000)
+$3.895M
(+369.19%)
Implied price effect (QoQ)
+45.86%
Shares
Total shares
39,758
QoQ shares delta
+27,398
(+221.67%)
Total shares held by funds (by quarter)
Top holders (Q3 2013)
Top 25 only
Full list
Partial Q3 2013 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BANK OF MONTREAL /CAN/ | 3,537 | 28,359 | 0.01% |
| DIAM Co., Ltd. | 1,159 | 9,299 | 0.02% |
| E. Ohman J:or Asset Management AB | 236 | 1,900 | 0.06% |
| FTB Advisors, Inc. | 15 | 169 | 0.01% |
| VICTORY CAPITAL MANAGEMENT INC | 3 | 31 | 0.0% |